Skip to main content

Table 1 Baseline Differences between Those with Mild to Moderate AD with Slow Gait Speed at Baseline and Those Without (Univariate Analysis). ADAS-Cog = Alzheimer Disease Assessment Scale – Cognitive Subsection; CDR-Sb: Clinical Dementia Rating, Sum of Boxes, BMI: Body Mass Index

From: Gait speed, cognition and falls in people living with mild-to-moderate Alzheimer disease: data from NILVAD

CharacteristicNo Slow Gait Speed
(N = 332)
Slow Gait Speed
(N = 37)
P-Value
Age, mean (SD)72.25 (8.02)77.68 (6.75)< 0.001*
Gender, female (%)207 (62.35%)26 (70.27%)0.343
BMI, mean (SD)25.44 (4.23)27.97 (5.56)0.005*
Group, nilvadipine (%)169 (50.9%)18 (48.65%)0.795
Diagnosis Duration, median (IQR)0.90 (0.43–2.22)1.01 (0.48–1.71)0.687
Symptom Duration, median (IQR)3.69 (2.20–5.25)3.45 (2.50–4.28)0.689
Education, median (IQR)16 (14–18)14 (12–16)0.003*
Total Medications, median (IQR)5 (3–6.5)5 (4–8)0.022*
Antidepressant Use, N (%)126 (37.95%)18 (48.65%)0.206
Benzodiazepine Use, N (%)40 (12.05%)3 (8.11%)0.479
Total Comorbidities, median (IQR)4 (2–5)4 (3–6)0.009*
Diabetes, N (%)22 (6.63%)5 (13.51%)0.297
Hypertension, N (%)94 (28.40%)14 (37.84%)0.232
Arthritis, N (%)26 (7.83%)4 (10.81)0.529
Baseline ADAS-Cog, mean (SD)32.49 (9.49)37.29 (11.56)0.002*
Baseline CDR-Sb, mean (SD)4.67 (2.44)6.13 (2.84)0.004*
\